首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction
【24h】

Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction

机译:互变异构素通过T细胞特异性凋亡诱导作用在体内和体外的免疫抑制作用

获取原文
获取原文并翻译 | 示例
       

摘要

Tautomycetin (TMC) was identified as an immunosuppressor of activated T cells. Inhibition of T cell proliferation with TMC was observed at concentrations 100-fold lower than those needed to achieve maximal inhibition with cyclosporin A (CsA). TMC specif- ically blocked tyrosine phosphorylation of intracellular signal me- diators downstream of Src tyrosine kinases in a T cell-specific manner, leading to apoptosis due to cleavage of Bcl-2, caspase-9, caspase-3, and poly(ADP-ribose) polymerase, but not caspase-1. In TMC-treated rats that received a heterotopic cardiac allograft, the graft survived more than 160 days, comparable to graft survival in allografted rats treated with CsA.
机译:互变霉素(TMC)被鉴定为活化T细胞的免疫抑制剂。用TMC抑制T细胞增殖的浓度比用环孢菌素A(CsA)达到最大抑制所需的浓度低100倍。 TMC以T细胞特异性方式特异性阻断Src酪氨酸激酶下游的细胞内信号介导物的酪氨酸磷酸化,由于Bcl-2,caspase-9,caspase-3和poly(ADP-核糖)聚合酶,而不是caspase-1。在接受异位心脏同种异体移植的TMC治疗大鼠中,移植物存活了160天以上,与用CsA处理的同种异体移植大鼠的存活率相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号